Natco Pharma shines on plan of launching 8-10 branded formulations during FY18

05 Jun 2017 Evaluate

Natco Pharma is currently trading at Rs. 968.20, up by 13.70 points or 1.44% from its previous closing of Rs. 954.50 on the BSE.

The scrip opened at Rs. 958.70 and has touched a high and low of Rs. 977.00 and Rs. 958.70 respectively. So far 20996 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1015.00 on 18-Apr-2017 and a 52 week low of Rs. 480.00 on 03-Jun-2016.

Last one week high and low of the scrip stood at Rs. 977.00 and Rs. 875.00 respectively. The current market cap of the company is Rs. 16865.15 crore.

The promoters holding in the company stood at 51.24%, while institutions and non-institutions held 26.70% and 22.05% respectively.

In a bid to achieve 20% growth year-on-year, Natco Pharma is planning to launch around 8-10 new products in domestic branded formulations segment during FY18. The Hyderabad-based drug firm is also planning to maintain its leadership position in oncology and gastro hepatology segment during the year as part of its short-term growth plan.

Moreover, the company is looking at gaining traction in the newly launched cardiology and diabetology (CnD) division. The company is also planning to expand its Hepatitis-C product portfolio during the year.

Natco Pharma Share Price

903.55 6.50 (0.72%)
31-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.75
Dr. Reddys Lab 1271.05
Cipla 1510.90
Zydus Lifesciences 914.65
Lupin 2112.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×